Myelodysplastic Syndromes

Research

Hematologists at Mayo Clinic are actively researching myelodysplastic syndromes in the hope of improving treatments. The myeloid disease group at Mayo Clinic includes basic scientists and clinicians. Because current MDS treatments are unable to cure the disease, Mayo researchers are committed to evaluating new drug therapies. Research includes on-site efforts, an ongoing collaboration with the University of Oxford in the United Kingdom, and cooperation with researchers at other institutions.

Drugs that appear promising in the laboratory and are expected to be relatively safe are tested in clinical trials through the Mayo Clinic Cancer Center. The list of available clinical trials continually changes.

Decisions about participating in a clinical trial, supportive care or other therapy depends on individual circumstances and needs. Mayo Clinic hematologists provide in-depth consultations to help each patient make the best decisions for treatment.

Publications

See a list of publications by Mayo Clinic doctors on myelodysplastic syndromes on PubMed, a service of the National Library of Medicine.